shortagewatch

Home / Respiratory system / Montelukast

ATC R03DC03 · Drugs for Obstructive Airway Diseases

Montelukast shortage

As of 31 Oct 2026, Montelukast has a reported shortage in 4 of the 5 countries we track (Italy, Spain, Austria, Belgium), covering 12 products.

Countries4/5
Products12packs or presentations
Short since1 May 20242.5 years ago
Earliest return24 Nov 2026company estimate
No return date7products
Main reasonManufacturing problem
GermanyNo reported shortageItaly4 packs shortSpain3 packs shortAustria3 packs shortBelgium2 packs short

Timeline

ItalySpainAustriaBelgium
202520262027SASLONGSASLONGMONTELUKAST ACCORDMONTELUKAST ACCORDMONTELUKAST VIATRIS 5 MG COMPRIMIDOS MASTICAMONTELUKAST VIATRIS 5 MG COMPRIMIDOS MASTICABLES EFG, 28 comprimidos (Al/Al)MONTELUKAST KERN PHARMA 4 mg COMPRIMIDOS MASMONTELUKAST KERN PHARMA 4 mg COMPRIMIDOS MASTICABLES EFG, 28 comprimidosMONTELUKAST VIATRIS 4 MG COMPRIMIDOS MASTICAMONTELUKAST VIATRIS 4 MG COMPRIMIDOS MASTICABLES EFG, 28 comprimidos (Al/Al)Lanair 4 mg - Kautabletten, 30 StückLanair 4 mg - Kautabletten, 30 StückLanair 5 mg - Kautabletten, 30 StückLanair 5 mg - Kautabletten, 30 StückLanair 10 mg - Filmtabletten, 30 StückLanair 10 mg - Filmtabletten, 30 StückMontelukast Teva 10 mg (Impexeco) film-coat.Montelukast Teva 10 mg (Impexeco) film-coat. tabl. 98Montelukast Sandoz 10 mg (Impexeco) film-coaMontelukast Sandoz 10 mg (Impexeco) film-coat. tabl. 98today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITSASLONGSO.SE.PHARM S.R.L. SOCIETA' DI SERVIZIO PER L'INDUSTRIA FARMACEUTICA ED AFFINI1 May 2024not givenManufacturing problem
Problemi produttivi
ITMONTELUKAST ACCORDACCORD HEALTHCARE, S.L.U.27 Feb 2026not givenIncreased demand
Elevata richiesta
ITMONTELUKAST MYLAN GENERICS announcedMYLAN S.P.A.7 Nov 2026not givenManufacturing problem
Problemi produttivi
ITMONTELUKAST AUROBINDO announcedAUROBINDO PHARMA (ITALIA) S.R.L.22 Dec 2026not givenManufacturing problem
Problemi produttivi
ESMONTELUKAST VIATRIS 5 MG COMPRIMIDOS MASTICABLES EFG, 28 comprimidos (Al/Al)Viatris Limited7 Apr 202623 Mar 2027Not stated
ESMONTELUKAST KERN PHARMA 4 mg COMPRIMIDOS MASTICABLES EFG, 28 comprimidosKern Pharma S.L.24 Aug 202624 Nov 2026Not stated
ESMONTELUKAST VIATRIS 4 MG COMPRIMIDOS MASTICABLES EFG, 28 comprimidos (Al/Al)Viatris Limited18 Oct 202623 Mar 2027Not stated
ATLanair 4 mg - Kautabletten, 30 StückG.L. Pharma GmbH15 Jan 2026not givenRegulatory or licensing
Regulatorische Änderungen
ATLanair 5 mg - Kautabletten, 30 StückG.L. Pharma GmbH15 Jan 2026not givenRegulatory or licensing
Regulatorische Änderungen
ATLanair 10 mg - Filmtabletten, 30 StückG.L. Pharma GmbH10 Feb 2026not givenRegulatory or licensing
Regulatorische Änderungen
BEMontelukast Teva 10 mg (Impexeco) film-coat. tabl. 98Impexeco18 Jun 202630 Nov 2026Other
Other reason
BEMontelukast Sandoz 10 mg (Impexeco) film-coat. tabl. 98Impexeco29 Oct 202631 Dec 2026Other
Other reason

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.